Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Stephen J Luen, Roberto Salgado, Stephen Fox, Peter Savas, Jennifer Eng-Wong, Emma Clark, Astrid Kiermaier, Sandra M Swain, Jose Baselga, Stefan Michiels, Sherene Loi
The Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2017
Awarded by NATIONAL CANCER INSTITUTE
F Hoffmann-La Roche-Genentech and the Breast Cancer Research Foundation.